Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription


1 Exp Brain Res
2 J Neural Transm (Vienna)
6 Mov Disord
1 Neurobiol Dis
1 Neurochem Res
1 Neuron
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Exp Brain Res

  1. CHETIA PHUKAN B, Dutta A, Deb S, Saikia R, et al
    Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.
    Exp Brain Res. 2021 Oct 11. pii: 10.1007/s00221-021-06237.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  2. RIEDERER P, Monoranu C, Strobel S, Iordache T, et al
    Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
    J Neural Transm (Vienna). 2021 Oct 12. pii: 10.1007/s00702-021-02414.
    PubMed         Abstract available

  3. RAGHU ALB, Parker T, Zand APD, Payne S, et al
    Tractography patterns of pedunculopontine nucleus deep brain stimulation.
    J Neural Transm (Vienna). 2021;128:659-670.
    PubMed         Abstract available

    Mov Disord

  4. ANDERSEN KB, Hansen AK, Damholdt MF, Horsager J, et al
    Reduced Synaptic Density in Patients with Lewy Body Dementia: An [(11) C]UCB-J PET Imaging Study.
    Mov Disord. 2021;36:2057-2065.
    PubMed         Abstract available

  5. MAJBOUR NK, Abdi IY, Dakna M, Wicke T, et al
    Cerebrospinal alpha-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort.
    Mov Disord. 2021;36:2048-2056.
    PubMed         Abstract available

  6. ISHIMOTO T, Yamakado H
    Membranes and Organelle in Lewy Bodies: The Mastermind or the Bystander?
    Mov Disord. 2021;36:2026.

  7. JARAZO J, Barmpa K, Modamio J, Saraiva C, et al
    Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-beta-Cyclodextrin Treatment.
    Mov Disord. 2021 Oct 12. doi: 10.1002/mds.28810.
    PubMed         Abstract available

  8. HUXFORD B, Haque T, Joseph AB, Simonet C, et al
    Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity.
    Mov Disord. 2021 Oct 13. doi: 10.1002/mds.28829.

  9. TSUKITA K, Sakamaki-Tsukita H, Takahashi R
    Lower Circulating Lymphocyte Count Predicts ApoE epsilon4-Related Cognitive Decline in Parkinson's Disease.
    Mov Disord. 2021 Oct 13. doi: 10.1002/mds.28799.

    Neurobiol Dis

  10. HU S, Tan J, Qin L, Lv L, et al
    Molecular chaperones and Parkinson's disease.
    Neurobiol Dis. 2021;160:105527.
    PubMed         Abstract available

    Neurochem Res

  11. MISHRA AK, Dixit A
    Dopaminergic Axons: Key Recitalists in Parkinson's Disease.
    Neurochem Res. 2021 Oct 12. pii: 10.1007/s11064-021-03464.
    PubMed         Abstract available


  12. SEO BA, Kim D, Hwang H, Kim MS, et al
    TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.
    Neuron. 2021 Oct 4. pii: S0896-6273(21)00704.
    PubMed         Abstract available

    PLoS One

  13. PARDOEL S, Shalin G, Lemaire ED, Kofman J, et al
    Grouping successive freezing of gait episodes has neutral to detrimental effect on freeze detection and prediction in Parkinson's disease.
    PLoS One. 2021;16:e0258544.
    PubMed         Abstract available

  14. AOUN K, Double KL, Pearson-Dennett V, Yilmaz R, et al
    Measurement of the adult human midbrain with transcranial ultrasound.
    PLoS One. 2021;16:e0247920.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.